Arkolith/Insider Trading/CRNX/Form 4

Betz Stephen F.

Chief Scientific OfficerCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$397K
Net Open-Market Flow
-$397K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)6K$37.11$236K141K
Mar 16, 2026Sell(S)4K$37.77$160K137K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-019498) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML